Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma

Background: Messenger ribonucleic acid (mRNA) vaccine has been considered as a potential therapeutic strategy and the next research hotspot, but their efficacy against prostate adenocarcinoma (PRAD) remains undefined. This study aimed to find potential antigens of PRAD for mRNA vaccine development a...

Full description

Bibliographic Details
Main Authors: Yukui Gao, Guixin Wang, Yanzhuo Chen, Mingpeng Zhang, Wenlong Gao, Zhiqun Shang, Yuanjie Niu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.886983/full